logo
Plus   Neg
Share
Email

A.P. Møller - Mærsk Reports Profit From Cont. Ops. In Q3; Revenue Down 0.9%

A.P. Møller - Mærsk A/S (AMKAF.PK,AMKBF.PK) reported third-quarter profit from continuing operations of $520 million compared to a loss of $173 million, last year. EBITDA increased by 14 percent to $1.7 billion, reflecting an EBITDA margin of 16.5 percent compared to 14.3 percent. Underlying profit for continuing operations after financial items and tax was $452 million compared to $188 million. The company noted that the financials are materially impacted by the implementation of IFRS 16.

Third-quarter revenue decreased by 0.9 percent to $10.1 billion, as the increase in Logistics & Services and Terminals & Towage with Ocean on par was offset by a decline in Manufacturing & Others.

For 2019, A.P. Moller - Maersk expects EBITDA in the range of $5.4-$5.8 billion from previously around $5.0 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. (EBAY) Wednesday reported a fourth-quarter profit that trumped Wall Street analysts' estimates, as did revenues. However, shares of the company slipped over 5% after the company issued a weak outlook for the first quarter. eBay's fourth-quarter profit dropped to $558 million or $0.69 per... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry.
RELATED NEWS
Follow RTT
>